systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.
| Name | M13_SLE |
|---|---|
| Long name | Systemic lupus erythematosus |
| Hospital Discharge registry | ICD-10: M32, ICD-8: 7431 |
| Cause of Death registry | ICD-10: M32, ICD-8: 7431 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Lupus erythematosus disseminatus (LED) |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 538 | 448 | 90 |
| Unadjusted prevalence (%) | 0.25 | 0.36 | 0.10 |
| Mean age at first event (years) | 45.61 | 44.85 | 49.36 |
| Case fatality at 5-years (%) | 3.16 | 3.13 | 3.33 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 6.0 | 7.0 | 4.0 |
| Recurrence at 6 months (%) | 67.47 | 67.86 | 65.56 |
before Systemic lupus erythematosus
after Systemic lupus erythematosus
Loading survival analyses plot…
Loading survival analyses table…